Global Non-Opioid Patch Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Non-Opioid Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Opioid Patch.
The Non-Opioid Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-Opioid Patch market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Opioid Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Opioid Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Non-Opioid Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-Opioid Patch market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Opioid Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- NEXGEL Advanced Hydrogel Solutions
- Viatris Inc.
- Johnson and Johnson
- Teva Pharmaceutical Industries Ltd
- Sorrento Therapeutics Inc.
- Hisamitsu Pharmaceutical Co.,Inc.
- Endo International plc.
- Purdue Pharma L.P.
- Amneal Pharmaceuticals LLC
- Grunenthal
- Prescription Medicines
- OTC Medicines
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Opioid Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 NON-OPIOID PATCH MARKET OVERVIEW
1.1 Product Overview and Scope of Non-Opioid Patch
1.2 Non-Opioid Patch Segment by Type
1.2.1 Global Non-Opioid Patch Market Value Comparison by Type (2023-2029)
1.2.2 Prescription Medicines
1.2.3 OTC Medicines
1.3 Non-Opioid Patch Segment by Application
1.3.1 Global Non-Opioid Patch Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-Opioid Patch Market Size Estimates and Forecasts
1.4.1 Global Non-Opioid Patch Revenue 2018-2029
1.4.2 Global Non-Opioid Patch Sales 2018-2029
1.4.3 Global Non-Opioid Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NON-OPIOID PATCH MARKET COMPETITION BY MANUFACTURERS
2.1 Global Non-Opioid Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-Opioid Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-Opioid Patch Average Price by Manufacturers (2018-2023)
2.4 Global Non-Opioid Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
2.7 Non-Opioid Patch Market Competitive Situation and Trends
2.7.1 Non-Opioid Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Opioid Patch Players Market Share by Revenue
2.7.3 Global Non-Opioid Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NON-OPIOID PATCH RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Non-Opioid Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Opioid Patch Global Non-Opioid Patch Sales by Region: 2018-2029
3.2.1 Global Non-Opioid Patch Sales by Region: 2018-2023
3.2.2 Global Non-Opioid Patch Sales by Region: 2024-2029
3.3 Global Non-Opioid Patch Global Non-Opioid Patch Revenue by Region: 2018-2029
3.3.1 Global Non-Opioid Patch Revenue by Region: 2018-2023
3.3.2 Global Non-Opioid Patch Revenue by Region: 2024-2029
3.4 North America Non-Opioid Patch Market Facts & Figures by Country
3.4.1 North America Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Opioid Patch Sales by Country (2018-2029)
3.4.3 North America Non-Opioid Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Opioid Patch Market Facts & Figures by Country
3.5.1 Europe Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Opioid Patch Sales by Country (2018-2029)
3.5.3 Europe Non-Opioid Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Opioid Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Opioid Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Opioid Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Opioid Patch Market Facts & Figures by Country
3.7.1 Latin America Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Opioid Patch Sales by Country (2018-2029)
3.7.3 Latin America Non-Opioid Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Opioid Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Opioid Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Opioid Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Non-Opioid Patch Sales by Type (2018-2029)
4.1.1 Global Non-Opioid Patch Sales by Type (2018-2023)
4.1.2 Global Non-Opioid Patch Sales by Type (2024-2029)
4.1.3 Global Non-Opioid Patch Sales Market Share by Type (2018-2029)
4.2 Global Non-Opioid Patch Revenue by Type (2018-2029)
4.2.1 Global Non-Opioid Patch Revenue by Type (2018-2023)
4.2.2 Global Non-Opioid Patch Revenue by Type (2024-2029)
4.2.3 Global Non-Opioid Patch Revenue Market Share by Type (2018-2029)
4.3 Global Non-Opioid Patch Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Non-Opioid Patch Sales by Application (2018-2029)
5.1.1 Global Non-Opioid Patch Sales by Application (2018-2023)
5.1.2 Global Non-Opioid Patch Sales by Application (2024-2029)
5.1.3 Global Non-Opioid Patch Sales Market Share by Application (2018-2029)
5.2 Global Non-Opioid Patch Revenue by Application (2018-2029)
5.2.1 Global Non-Opioid Patch Revenue by Application (2018-2023)
5.2.2 Global Non-Opioid Patch Revenue by Application (2024-2029)
5.2.3 Global Non-Opioid Patch Revenue Market Share by Application (2018-2029)
5.3 Global Non-Opioid Patch Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 NEXGEL Advanced Hydrogel Solutions
6.1.1 NEXGEL Advanced Hydrogel Solutions Corporation Information
6.1.2 NEXGEL Advanced Hydrogel Solutions Description and Business Overview
6.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
6.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
6.2 Viatris Inc.
6.2.1 Viatris Inc. Corporation Information
6.2.2 Viatris Inc. Description and Business Overview
6.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris Inc. Non-Opioid Patch Product Portfolio
6.2.5 Viatris Inc. Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Teva Pharmaceutical Industries Ltd
6.4.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.4.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
6.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.5 Sorrento Therapeutics Inc.
6.5.1 Sorrento Therapeutics Inc. Corporation Information
6.5.2 Sorrento Therapeutics Inc. Description and Business Overview
6.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
6.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
6.6 Hisamitsu Pharmaceutical Co.,Inc.
6.6.1 Hisamitsu Pharmaceutical Co.,Inc. Corporation Information
6.6.2 Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
6.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
6.7 Endo International plc.
6.6.1 Endo International plc. Corporation Information
6.6.2 Endo International plc. Description and Business Overview
6.6.3 Endo International plc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Endo International plc. Non-Opioid Patch Product Portfolio
6.7.5 Endo International plc. Recent Developments/Updates
6.8 Purdue Pharma L.P.
6.8.1 Purdue Pharma L.P. Corporation Information
6.8.2 Purdue Pharma L.P. Description and Business Overview
6.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
6.8.5 Purdue Pharma L.P. Recent Developments/Updates
6.9 Amneal Pharmaceuticals LLC
6.9.1 Amneal Pharmaceuticals LLC Corporation Information
6.9.2 Amneal Pharmaceuticals LLC Description and Business Overview
6.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
6.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
6.10 Grunenthal
6.10.1 Grunenthal Corporation Information
6.10.2 Grunenthal Description and Business Overview
6.10.3 Grunenthal Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Grunenthal Non-Opioid Patch Product Portfolio
6.10.5 Grunenthal Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Non-Opioid Patch Industry Chain Analysis
7.2 Non-Opioid Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Opioid Patch Production Mode & Process
7.4 Non-Opioid Patch Sales and Marketing
7.4.1 Non-Opioid Patch Sales Channels
7.4.2 Non-Opioid Patch Distributors
7.5 Non-Opioid Patch Customers
8 NON-OPIOID PATCH MARKET DYNAMICS
8.1 Non-Opioid Patch Industry Trends
8.2 Non-Opioid Patch Market Drivers
8.3 Non-Opioid Patch Market Challenges
8.4 Non-Opioid Patch Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Non-Opioid Patch
1.2 Non-Opioid Patch Segment by Type
1.2.1 Global Non-Opioid Patch Market Value Comparison by Type (2023-2029)
1.2.2 Prescription Medicines
1.2.3 OTC Medicines
1.3 Non-Opioid Patch Segment by Application
1.3.1 Global Non-Opioid Patch Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-Opioid Patch Market Size Estimates and Forecasts
1.4.1 Global Non-Opioid Patch Revenue 2018-2029
1.4.2 Global Non-Opioid Patch Sales 2018-2029
1.4.3 Global Non-Opioid Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NON-OPIOID PATCH MARKET COMPETITION BY MANUFACTURERS
2.1 Global Non-Opioid Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-Opioid Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-Opioid Patch Average Price by Manufacturers (2018-2023)
2.4 Global Non-Opioid Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
2.7 Non-Opioid Patch Market Competitive Situation and Trends
2.7.1 Non-Opioid Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Opioid Patch Players Market Share by Revenue
2.7.3 Global Non-Opioid Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NON-OPIOID PATCH RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Non-Opioid Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Opioid Patch Global Non-Opioid Patch Sales by Region: 2018-2029
3.2.1 Global Non-Opioid Patch Sales by Region: 2018-2023
3.2.2 Global Non-Opioid Patch Sales by Region: 2024-2029
3.3 Global Non-Opioid Patch Global Non-Opioid Patch Revenue by Region: 2018-2029
3.3.1 Global Non-Opioid Patch Revenue by Region: 2018-2023
3.3.2 Global Non-Opioid Patch Revenue by Region: 2024-2029
3.4 North America Non-Opioid Patch Market Facts & Figures by Country
3.4.1 North America Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Opioid Patch Sales by Country (2018-2029)
3.4.3 North America Non-Opioid Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Opioid Patch Market Facts & Figures by Country
3.5.1 Europe Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Opioid Patch Sales by Country (2018-2029)
3.5.3 Europe Non-Opioid Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Opioid Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Opioid Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Opioid Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Opioid Patch Market Facts & Figures by Country
3.7.1 Latin America Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Opioid Patch Sales by Country (2018-2029)
3.7.3 Latin America Non-Opioid Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Opioid Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Opioid Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Opioid Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Opioid Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Non-Opioid Patch Sales by Type (2018-2029)
4.1.1 Global Non-Opioid Patch Sales by Type (2018-2023)
4.1.2 Global Non-Opioid Patch Sales by Type (2024-2029)
4.1.3 Global Non-Opioid Patch Sales Market Share by Type (2018-2029)
4.2 Global Non-Opioid Patch Revenue by Type (2018-2029)
4.2.1 Global Non-Opioid Patch Revenue by Type (2018-2023)
4.2.2 Global Non-Opioid Patch Revenue by Type (2024-2029)
4.2.3 Global Non-Opioid Patch Revenue Market Share by Type (2018-2029)
4.3 Global Non-Opioid Patch Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Non-Opioid Patch Sales by Application (2018-2029)
5.1.1 Global Non-Opioid Patch Sales by Application (2018-2023)
5.1.2 Global Non-Opioid Patch Sales by Application (2024-2029)
5.1.3 Global Non-Opioid Patch Sales Market Share by Application (2018-2029)
5.2 Global Non-Opioid Patch Revenue by Application (2018-2029)
5.2.1 Global Non-Opioid Patch Revenue by Application (2018-2023)
5.2.2 Global Non-Opioid Patch Revenue by Application (2024-2029)
5.2.3 Global Non-Opioid Patch Revenue Market Share by Application (2018-2029)
5.3 Global Non-Opioid Patch Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 NEXGEL Advanced Hydrogel Solutions
6.1.1 NEXGEL Advanced Hydrogel Solutions Corporation Information
6.1.2 NEXGEL Advanced Hydrogel Solutions Description and Business Overview
6.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
6.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
6.2 Viatris Inc.
6.2.1 Viatris Inc. Corporation Information
6.2.2 Viatris Inc. Description and Business Overview
6.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris Inc. Non-Opioid Patch Product Portfolio
6.2.5 Viatris Inc. Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Teva Pharmaceutical Industries Ltd
6.4.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.4.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
6.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.5 Sorrento Therapeutics Inc.
6.5.1 Sorrento Therapeutics Inc. Corporation Information
6.5.2 Sorrento Therapeutics Inc. Description and Business Overview
6.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
6.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
6.6 Hisamitsu Pharmaceutical Co.,Inc.
6.6.1 Hisamitsu Pharmaceutical Co.,Inc. Corporation Information
6.6.2 Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
6.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
6.7 Endo International plc.
6.6.1 Endo International plc. Corporation Information
6.6.2 Endo International plc. Description and Business Overview
6.6.3 Endo International plc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Endo International plc. Non-Opioid Patch Product Portfolio
6.7.5 Endo International plc. Recent Developments/Updates
6.8 Purdue Pharma L.P.
6.8.1 Purdue Pharma L.P. Corporation Information
6.8.2 Purdue Pharma L.P. Description and Business Overview
6.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
6.8.5 Purdue Pharma L.P. Recent Developments/Updates
6.9 Amneal Pharmaceuticals LLC
6.9.1 Amneal Pharmaceuticals LLC Corporation Information
6.9.2 Amneal Pharmaceuticals LLC Description and Business Overview
6.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
6.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
6.10 Grunenthal
6.10.1 Grunenthal Corporation Information
6.10.2 Grunenthal Description and Business Overview
6.10.3 Grunenthal Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Grunenthal Non-Opioid Patch Product Portfolio
6.10.5 Grunenthal Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Non-Opioid Patch Industry Chain Analysis
7.2 Non-Opioid Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Opioid Patch Production Mode & Process
7.4 Non-Opioid Patch Sales and Marketing
7.4.1 Non-Opioid Patch Sales Channels
7.4.2 Non-Opioid Patch Distributors
7.5 Non-Opioid Patch Customers
8 NON-OPIOID PATCH MARKET DYNAMICS
8.1 Non-Opioid Patch Industry Trends
8.2 Non-Opioid Patch Market Drivers
8.3 Non-Opioid Patch Market Challenges
8.4 Non-Opioid Patch Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Non-Opioid Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Non-Opioid Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Non-Opioid Patch Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-Opioid Patch Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Non-Opioid Patch Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Non-Opioid Patch Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Non-Opioid Patch Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Non-Opioid Patch Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Non-Opioid Patch, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
Table 12. Global Key Manufacturers of Non-Opioid Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Opioid Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Patch as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Opioid Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Non-Opioid Patch Sales by Region (2018-2023) & (K Units)
Table 18. Global Non-Opioid Patch Sales Market Share by Region (2018-2023)
Table 19. Global Non-Opioid Patch Sales by Region (2024-2029) & (K Units)
Table 20. Global Non-Opioid Patch Sales Market Share by Region (2024-2029)
Table 21. Global Non-Opioid Patch Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Non-Opioid Patch Revenue Market Share by Region (2018-2023)
Table 23. Global Non-Opioid Patch Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Non-Opioid Patch Revenue Market Share by Region (2024-2029)
Table 25. North America Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 27. North America Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 28. North America Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 32. Europe Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 33. Europe Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Non-Opioid Patch Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Non-Opioid Patch Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Non-Opioid Patch Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Non-Opioid Patch Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Non-Opioid Patch Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Non-Opioid Patch Sales (K Units) by Type (2018-2023)
Table 51. Global Non-Opioid Patch Sales (K Units) by Type (2024-2029)
Table 52. Global Non-Opioid Patch Sales Market Share by Type (2018-2023)
Table 53. Global Non-Opioid Patch Sales Market Share by Type (2024-2029)
Table 54. Global Non-Opioid Patch Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Non-Opioid Patch Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Non-Opioid Patch Revenue Market Share by Type (2018-2023)
Table 57. Global Non-Opioid Patch Revenue Market Share by Type (2024-2029)
Table 58. Global Non-Opioid Patch Price (US$/Unit) by Type (2018-2023)
Table 59. Global Non-Opioid Patch Price (US$/Unit) by Type (2024-2029)
Table 60. Global Non-Opioid Patch Sales (K Units) by Application (2018-2023)
Table 61. Global Non-Opioid Patch Sales (K Units) by Application (2024-2029)
Table 62. Global Non-Opioid Patch Sales Market Share by Application (2018-2023)
Table 63. Global Non-Opioid Patch Sales Market Share by Application (2024-2029)
Table 64. Global Non-Opioid Patch Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Non-Opioid Patch Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Non-Opioid Patch Revenue Market Share by Application (2018-2023)
Table 67. Global Non-Opioid Patch Revenue Market Share by Application (2024-2029)
Table 68. Global Non-Opioid Patch Price (US$/Unit) by Application (2018-2023)
Table 69. Global Non-Opioid Patch Price (US$/Unit) by Application (2024-2029)
Table 70. NEXGEL Advanced Hydrogel Solutions Corporation Information
Table 71. NEXGEL Advanced Hydrogel Solutions Description and Business Overview
Table 72. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product
Table 74. NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
Table 75. Viatris Inc. Corporation Information
Table 76. Viatris Inc. Description and Business Overview
Table 77. Viatris Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Viatris Inc. Non-Opioid Patch Product
Table 79. Viatris Inc. Recent Developments/Updates
Table 80. Johnson and Johnson Corporation Information
Table 81. Johnson and Johnson Description and Business Overview
Table 82. Johnson and Johnson Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson and Johnson Non-Opioid Patch Product
Table 84. Johnson and Johnson Recent Developments/Updates
Table 85. Teva Pharmaceutical Industries Ltd Corporation Information
Table 86. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 87. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product
Table 89. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 90. Sorrento Therapeutics Inc. Corporation Information
Table 91. Sorrento Therapeutics Inc. Description and Business Overview
Table 92. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sorrento Therapeutics Inc. Non-Opioid Patch Product
Table 94. Sorrento Therapeutics Inc. Recent Developments/Updates
Table 95. Hisamitsu Pharmaceutical Co.,Inc. Corporation Information
Table 96. Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
Table 97. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product
Table 99. Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
Table 100. Endo International plc. Corporation Information
Table 101. Endo International plc. Description and Business Overview
Table 102. Endo International plc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Endo International plc. Non-Opioid Patch Product
Table 104. Endo International plc. Recent Developments/Updates
Table 105. Purdue Pharma L.P. Corporation Information
Table 106. Purdue Pharma L.P. Description and Business Overview
Table 107. Purdue Pharma L.P. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Purdue Pharma L.P. Non-Opioid Patch Product
Table 109. Purdue Pharma L.P. Recent Developments/Updates
Table 110. Amneal Pharmaceuticals LLC Corporation Information
Table 111. Amneal Pharmaceuticals LLC Description and Business Overview
Table 112. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Amneal Pharmaceuticals LLC Non-Opioid Patch Product
Table 114. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 115. Grunenthal Corporation Information
Table 116. Grunenthal Description and Business Overview
Table 117. Grunenthal Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Grunenthal Non-Opioid Patch Product
Table 119. Grunenthal Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Non-Opioid Patch Distributors List
Table 123. Non-Opioid Patch Customers List
Table 124. Non-Opioid Patch Market Trends
Table 125. Non-Opioid Patch Market Drivers
Table 126. Non-Opioid Patch Market Challenges
Table 127. Non-Opioid Patch Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 1. Global Non-Opioid Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Non-Opioid Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Non-Opioid Patch Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-Opioid Patch Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Non-Opioid Patch Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Non-Opioid Patch Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Non-Opioid Patch Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Non-Opioid Patch Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Non-Opioid Patch, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
Table 12. Global Key Manufacturers of Non-Opioid Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Opioid Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Patch as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Opioid Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Non-Opioid Patch Sales by Region (2018-2023) & (K Units)
Table 18. Global Non-Opioid Patch Sales Market Share by Region (2018-2023)
Table 19. Global Non-Opioid Patch Sales by Region (2024-2029) & (K Units)
Table 20. Global Non-Opioid Patch Sales Market Share by Region (2024-2029)
Table 21. Global Non-Opioid Patch Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Non-Opioid Patch Revenue Market Share by Region (2018-2023)
Table 23. Global Non-Opioid Patch Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Non-Opioid Patch Revenue Market Share by Region (2024-2029)
Table 25. North America Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 27. North America Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 28. North America Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 32. Europe Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 33. Europe Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Non-Opioid Patch Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Non-Opioid Patch Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Non-Opioid Patch Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Non-Opioid Patch Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Non-Opioid Patch Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Non-Opioid Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Non-Opioid Patch Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Non-Opioid Patch Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non-Opioid Patch Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Non-Opioid Patch Sales (K Units) by Type (2018-2023)
Table 51. Global Non-Opioid Patch Sales (K Units) by Type (2024-2029)
Table 52. Global Non-Opioid Patch Sales Market Share by Type (2018-2023)
Table 53. Global Non-Opioid Patch Sales Market Share by Type (2024-2029)
Table 54. Global Non-Opioid Patch Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Non-Opioid Patch Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Non-Opioid Patch Revenue Market Share by Type (2018-2023)
Table 57. Global Non-Opioid Patch Revenue Market Share by Type (2024-2029)
Table 58. Global Non-Opioid Patch Price (US$/Unit) by Type (2018-2023)
Table 59. Global Non-Opioid Patch Price (US$/Unit) by Type (2024-2029)
Table 60. Global Non-Opioid Patch Sales (K Units) by Application (2018-2023)
Table 61. Global Non-Opioid Patch Sales (K Units) by Application (2024-2029)
Table 62. Global Non-Opioid Patch Sales Market Share by Application (2018-2023)
Table 63. Global Non-Opioid Patch Sales Market Share by Application (2024-2029)
Table 64. Global Non-Opioid Patch Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Non-Opioid Patch Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Non-Opioid Patch Revenue Market Share by Application (2018-2023)
Table 67. Global Non-Opioid Patch Revenue Market Share by Application (2024-2029)
Table 68. Global Non-Opioid Patch Price (US$/Unit) by Application (2018-2023)
Table 69. Global Non-Opioid Patch Price (US$/Unit) by Application (2024-2029)
Table 70. NEXGEL Advanced Hydrogel Solutions Corporation Information
Table 71. NEXGEL Advanced Hydrogel Solutions Description and Business Overview
Table 72. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product
Table 74. NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
Table 75. Viatris Inc. Corporation Information
Table 76. Viatris Inc. Description and Business Overview
Table 77. Viatris Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Viatris Inc. Non-Opioid Patch Product
Table 79. Viatris Inc. Recent Developments/Updates
Table 80. Johnson and Johnson Corporation Information
Table 81. Johnson and Johnson Description and Business Overview
Table 82. Johnson and Johnson Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson and Johnson Non-Opioid Patch Product
Table 84. Johnson and Johnson Recent Developments/Updates
Table 85. Teva Pharmaceutical Industries Ltd Corporation Information
Table 86. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 87. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product
Table 89. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 90. Sorrento Therapeutics Inc. Corporation Information
Table 91. Sorrento Therapeutics Inc. Description and Business Overview
Table 92. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sorrento Therapeutics Inc. Non-Opioid Patch Product
Table 94. Sorrento Therapeutics Inc. Recent Developments/Updates
Table 95. Hisamitsu Pharmaceutical Co.,Inc. Corporation Information
Table 96. Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
Table 97. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product
Table 99. Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
Table 100. Endo International plc. Corporation Information
Table 101. Endo International plc. Description and Business Overview
Table 102. Endo International plc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Endo International plc. Non-Opioid Patch Product
Table 104. Endo International plc. Recent Developments/Updates
Table 105. Purdue Pharma L.P. Corporation Information
Table 106. Purdue Pharma L.P. Description and Business Overview
Table 107. Purdue Pharma L.P. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Purdue Pharma L.P. Non-Opioid Patch Product
Table 109. Purdue Pharma L.P. Recent Developments/Updates
Table 110. Amneal Pharmaceuticals LLC Corporation Information
Table 111. Amneal Pharmaceuticals LLC Description and Business Overview
Table 112. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Amneal Pharmaceuticals LLC Non-Opioid Patch Product
Table 114. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 115. Grunenthal Corporation Information
Table 116. Grunenthal Description and Business Overview
Table 117. Grunenthal Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Grunenthal Non-Opioid Patch Product
Table 119. Grunenthal Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Non-Opioid Patch Distributors List
Table 123. Non-Opioid Patch Customers List
Table 124. Non-Opioid Patch Market Trends
Table 125. Non-Opioid Patch Market Drivers
Table 126. Non-Opioid Patch Market Challenges
Table 127. Non-Opioid Patch Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Non-Opioid Patch
Figure 2. Global Non-Opioid Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Non-Opioid Patch Market Share by Type in 2022 & 2029
Figure 4. Prescription Medicines Product Picture
Figure 5. OTC Medicines Product Picture
Figure 6. Global Non-Opioid Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Non-Opioid Patch Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Online Pharmacies
Figure 11. Global Non-Opioid Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Non-Opioid Patch Market Size (2018-2029) & (US$ Million)
Figure 13. Global Non-Opioid Patch Sales (2018-2029) & (K Units)
Figure 14. Global Non-Opioid Patch Average Price (US$/Unit) & (2018-2029)
Figure 15. Non-Opioid Patch Report Years Considered
Figure 16. Non-Opioid Patch Sales Share by Manufacturers in 2022
Figure 17. Global Non-Opioid Patch Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Non-Opioid Patch Players: Market Share by Revenue in 2022
Figure 19. Non-Opioid Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Non-Opioid Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 22. North America Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 23. United States Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 26. Europe Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 27. Germany Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Non-Opioid Patch Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Non-Opioid Patch Revenue Market Share by Region (2018-2029)
Figure 34. China Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 42. Latin America Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Non-Opioid Patch by Type (2018-2029)
Figure 52. Global Revenue Market Share of Non-Opioid Patch by Type (2018-2029)
Figure 53. Global Non-Opioid Patch Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Non-Opioid Patch by Application (2018-2029)
Figure 55. Global Revenue Market Share of Non-Opioid Patch by Application (2018-2029)
Figure 56. Global Non-Opioid Patch Price (US$/Unit) by Application (2018-2029)
Figure 57. Non-Opioid Patch Value Chain
Figure 58. Non-Opioid Patch Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Product Picture of Non-Opioid Patch
Figure 2. Global Non-Opioid Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Non-Opioid Patch Market Share by Type in 2022 & 2029
Figure 4. Prescription Medicines Product Picture
Figure 5. OTC Medicines Product Picture
Figure 6. Global Non-Opioid Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Non-Opioid Patch Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Online Pharmacies
Figure 11. Global Non-Opioid Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Non-Opioid Patch Market Size (2018-2029) & (US$ Million)
Figure 13. Global Non-Opioid Patch Sales (2018-2029) & (K Units)
Figure 14. Global Non-Opioid Patch Average Price (US$/Unit) & (2018-2029)
Figure 15. Non-Opioid Patch Report Years Considered
Figure 16. Non-Opioid Patch Sales Share by Manufacturers in 2022
Figure 17. Global Non-Opioid Patch Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Non-Opioid Patch Players: Market Share by Revenue in 2022
Figure 19. Non-Opioid Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Non-Opioid Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 22. North America Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 23. United States Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 26. Europe Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 27. Germany Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Non-Opioid Patch Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Non-Opioid Patch Revenue Market Share by Region (2018-2029)
Figure 34. China Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 42. Latin America Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Non-Opioid Patch Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Non-Opioid Patch Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Non-Opioid Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Non-Opioid Patch by Type (2018-2029)
Figure 52. Global Revenue Market Share of Non-Opioid Patch by Type (2018-2029)
Figure 53. Global Non-Opioid Patch Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Non-Opioid Patch by Application (2018-2029)
Figure 55. Global Revenue Market Share of Non-Opioid Patch by Application (2018-2029)
Figure 56. Global Non-Opioid Patch Price (US$/Unit) by Application (2018-2029)
Figure 57. Non-Opioid Patch Value Chain
Figure 58. Non-Opioid Patch Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
